Work

Pulmonary aspergillosis in two COVID-19 patients from Kuwait

Year: 2021

Type: article

Abstract: Critically ill patients with coronavirus disease 2019 (COVID-19) are at risk of invasive pulmonary aspergillosis. The clinical manifestations of a superimposed fungal infection in those patients are difficult to underpin. This is compounded by the non-specific radiological findings associated with this infection and the challenges associated with performing bronchoscopy in COVID-19 patients. We would like to present two COVID-19 cases who developed secondary Aspergillus pulmonary infection in the intensive care unit as shown by respiratory cultures, serum galactomannan and radiological images. Despite advanced intensive care and use of antifungal agents, both patients died eventually. This report illustrates the negative impact of secondary Aspergillosis and calls for the need of increased awareness of COVID19-associated pulmonary aspergillosis.

Source: Access Microbiology

DOI: 10.1099/acmi.0.000201

Authors: Khaled Alobaid, Beena Yousuf, Eman Al-Qattan, Zainab Muqeem, Nawaf Al-Subaie

Institutions: Mubarak Al Kabeer Hospital, Adan Hospital, Ministry of Health, Ahmadi Hospital-Kuwait Oil Company

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $858